Abstract
This article will focus on 3 avenues for future research: (1) addressing the lack of short- and long-term clinical outcome research on catheter-directed therapy; (2) determining the safety and efficacy of novel thrombus removal devices; and (3) translating our knowledge of the pathobiology and pathophysiology of pulmonary embolism into novel diagnostic and therapeutic strategies.
Keywords:
Pulmonary Embolism; Research; Thrombectomy; Thrombolysis.
Copyright © 2017 Elsevier Inc. All rights reserved.
MeSH terms
-
Catheterization, Swan-Ganz / adverse effects
-
Catheterization, Swan-Ganz / instrumentation
-
Catheterization, Swan-Ganz / trends*
-
Catheters / trends*
-
Clinical Trials as Topic / methods*
-
Diffusion of Innovation
-
Equipment Design
-
Fibrinolytic Agents / administration & dosage*
-
Fibrinolytic Agents / adverse effects
-
Forecasting
-
Humans
-
Infusions, Intra-Arterial
-
Professional Practice Gaps / trends*
-
Pulmonary Embolism / diagnosis
-
Pulmonary Embolism / physiopathology
-
Pulmonary Embolism / therapy*
-
Research Design / trends*
-
Risk Factors
-
Thrombolytic Therapy / adverse effects
-
Thrombolytic Therapy / instrumentation
-
Thrombolytic Therapy / trends*
-
Treatment Outcome